KVP Capital Advisors, LP — 13F Holdings & Portfolio
CIK 1858198 · latest 13F-HR filed 2026-05-13
KVP Capital Advisors, LP manages $133.9M in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are TERN (17.32%), PRAX (10.32%), WHWK (5.58%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 9 new positions, exited 2, added to 12, and trimmed 9.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$133.9M
Long-equity book
32
Distinct positions
2026-03-31
Filed 2026-05-13
+9 / −2 / ↑12 / ↓9
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- TERNS PHARMACEUTICALS INC$5.4M +30.5%
- WHITEHAWK THERAPEUTICS INC$2.2M +42.6%
- REVOLUTION MEDICINES INC$1.7M +78.5%
- PRAXIS PRECISION MEDICINES I$1.2M +9.3%
- PROTAGONIST THERAPEUTICS INC$957.2K +20.7%
Top Trims
- ACHIEVE LIFE SCIENCES INC-$938.6K -40.8%
- DISC MEDICINE INC-$901.1K -19.5%
- TRAVERE THERAPEUTICS INC-$773.5K -22.2%
- SOLENO THERAPEUTICS INC-$765.4K -27.7%
- AXSOME THERAPEUTICS INC-$493.0K -7.5%
New Positions
- SUTRO BIOPHARMA INC$5.6M
- ERASCA INC$5.5M
- TANGO THERAPEUTICS INC$4.8M
- IDEAYA BIOSCIENCES INC$2.7M
- COMPASS THERAPEUTICS INC$2.6M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | TERN | 880881107 | $23.2M | 17.32% | 440,000 | SH |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $13.8M | 10.32% | 42,900 | SH |
| 3 | WHITEHAWK THERAPEUTICS INC | WHWK | 00032Q104 | $7.5M | 5.58% | 2,165,997 | SH |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 05464T104 | $6.1M | 4.57% | 36,200 | SH |
| 5 | SUTRO BIOPHARMA INC | STRO | 869367201 | $5.6M | 4.22% | 226,575 | SH |
| 6 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $5.6M | 4.17% | 53,000 | SH |
| 7 | ERASCA INC | ERAS | 29479A108 | $5.5M | 4.11% | 340,000 | SH |
| 8 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $4.9M | 3.69% | 414,000 | SH |
| 9 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $4.8M | 3.60% | 230,264 | SH |
| 10 | INSMED INC | INSM | 457669307 | $4.7M | 3.48% | 28,497 | SH |
| 11 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $4.2M | 3.13% | 133,000 | SH |
| 12 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $3.9M | 2.92% | 40,200 | SH |
| 13 | DISC MEDICINE INC | IRON | 254604101 | $3.7M | 2.78% | 58,250 | SH |
| 14 | MBX BIOSCIENCES INC | MBX | 55287L101 | $3.6M | 2.71% | 121,524 | SH |
| 15 | SAVARA INC | SVRA | 805111101 | $3.3M | 2.47% | 605,280 | SH |
| 16 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $2.8M | 2.10% | 4,750 | SH |
| 17 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $2.7M | 2.02% | 91,000 | SH |
| 18 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $2.7M | 1.98% | 79,700 | SH |
| 19 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $2.6M | 1.98% | 500,000 | SH |
| 20 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $2.5M | 1.90% | 300,000 | SH |
| 21 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $2.4M | 1.83% | 125,000 | SH |
| 22 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $2.3M | 1.73% | 31,813 | SH |
| 23 | ZURA BIO LTD | ZURA | G9TY5A101 | $2.2M | 1.66% | 373,128 | SH |
| 24 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $2.2M | 1.65% | 45,000 | SH |
| 25 | IMMIX BIOPHARMA INC | IMMX | 45258H106 | $2.1M | 1.57% | 230,423 | SH |
| 26 | SOLENO THERAPEUTICS INC | SLNO | 834203309 | $2.0M | 1.49% | 59,700 | SH |
| 27 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $1.9M | 1.45% | 26,900 | SH |
| 28 | CABALETTA BIO INC | CABA | 12674W109 | $1.4M | 1.02% | 505,431 | SH |
| 29 | ACHIEVE LIFE SCIENCES INC | ACHV | 004468500 | $1.4M | 1.02% | 462,355 | SH |
| 30 | VERA THERAPEUTICS INC | VERA | 92337R101 | $1.3M | 0.98% | 32,700 | SH |
| 31 | CELCUITY INC | CELC | 15102K100 | $456.6K | 0.34% | 4,000 | SH |
| 32 | VYNE THERAPEUTICS INC | VYNE | 92941V308 | $299.1K | 0.22% | 500,551 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | $133.9M | 32 | 0001104659-26-060329 |
| 2025-12-31 | 2026-02-18 | $103.3M | 27 | 0001104659-26-016901 |